Pediatricians
44 years of experience

Accepting new patients
9880 Buffleton Ave
Fl 2
Philadelphia, PA 19111
215-456-6786
Locations and availability (3)

Education ?

Medical School Score
Thomas Jefferson University (1966)
  • Currently 2 of 4 apples

Awards & Distinctions ?

Associations
American Board of Pediatrics

Affiliations ?

Dr. Girone is affiliated with 5 hospitals.

Hospital Affilations

Score

Rankings

  • Saint Joseph Medical Center
    145 N 6th St, Reading, PA 19601
    • Currently 4 of 4 crosses
    Top 25%
  • The Reading Hospital and Medical Center
    300 S 6th Ave, Reading, PA 19611
    • Currently 3 of 4 crosses
    Top 50%
  • Grand View Hospital
    700 Lawn Ave, Sellersville, PA 18960
    • Currently 3 of 4 crosses
    Top 50%
  • Albert Einstein Medical Center
    5501 Old York Rd, Philadelphia, PA 19141
    • Currently 3 of 4 crosses
    Top 50%
  • Saint Christopher's Hospital for Children
    3601 A St, Philadelphia, PA 19134
    • Currently 2 of 4 crosses
  • Publications & Research

    Dr. Girone has contributed to 12 publications.
    Title Little Stories.
    Date February 2004
    Journal Archives of Pediatrics & Adolescent Medicine
    Title Religion and Medicine - Responses.
    Date January 2001
    Journal Medgenmed : Medscape General Medicine
    Title Oral Pyridoxine in the Prevention of Oxalate Kidney Stones.
    Date March 1997
    Journal American Journal of Nephrology
    Title Bad News and Very Bad News.
    Date April 1995
    Journal Pennsylvania Medicine
    Title Response of 7- to 15-month-old Infants to Sequential Immunization with Haemophilus Influenzae Type B-crm197 Conjugate and Polysaccharide Vaccines.
    Date August 1991
    Journal American Journal of Diseases of Children (1960)
    Excerpt

    OBJECTIVE. To evaluate the immunologic potential of infants 7 to 15 months of age to respond to Haemophilus influenzae type b polysaccharide vaccine following immunization with H influenzae b oligosaccharide-CRM197 conjugate vaccine. STUDY DESIGN. One hundred seventy-one infants, aged 7 to 15 months, were consecutively and alternatively assigned to one of three immunization protocols. Group 1 (n = 71) received three doses of H influenzae b oligosaccharide-CRM197 conjugate vaccine, group 2 (n = 47) received two doses of H influenzae b oligosaccharide-CRM197 conjugate vaccine followed by one dose of H influenzae type b polysaccharide vaccine, and group 3 received one dose of H influenzae b oligosaccharide-CRM197 conjugate vaccine followed by two doses of H influenzae type b polysaccharide vaccine. Immunizations were given on day 0 and at 2 months and 6 months. Anti-H influenzae type b polysaccharide antibody levels were measured on day 0 and 2, 3, 6, 7, and 12 months after the study began. RESULTS. Haemophilus influenzae type b polysaccharide vaccine given as a second dose stimulated an antibody rise but did so less effectively than H influenzae b oligosaccharide-CRM197 conjugate vaccine. Two doses of H influenzae b oligosaccharide-CRM197 conjugate vaccine were highly immunogenic; geometric means were 31 and 35 micrograms/mL in the 7- to 11-month and 12- to 15-month age groups, respectively. Following two doses of H influenzae b oligosaccharide-CRM197 conjugate vaccine, both immunization protocols resulted in (1) equally high geometric mean antibody levels 1 month after immunization and (2) similar geometric mean antibody levels 6 months after immunization. CONCLUSIONS. Haemophilus influenzae b oligosaccharide-CRM197 conjugate vaccine induces antibody levels that would be expected to protect infants from initial invasion and primes the immune system for an anamnestic response. Our data indicate that if a booster immunization is needed, H influenzae type b polysaccharide vaccine could be an alternative to H influenzae b oligosaccharide-CRM197 conjugate vaccine.

    Title Comparison of Antigenuria After Immunization with Three Haemophilus Influenzae Type B Conjugate Vaccines.
    Date August 1991
    Journal The Pediatric Infectious Disease Journal
    Excerpt

    The incidence of antigenuria was documented after vaccination of 75 children 15 to 60 months of age with one of three Haemophilus influenzae type b conjugate vaccines, PRP-D (ProHIBiT), PRP-T and HbOC (HibTITER). Unconcentrated and concentrated urine was tested on the first, third, fifth and seventh days after vaccination. Antigenuria occurred on Day 1 in 100% of PRP-D, 43% of PRP-T and 12% of HbOC recipients. The percentages of children excreting antigen on Day 3 were 95, 17 and 8%; on Day 5 they were 36, 4 and 12%; and on Day 7 they were 14, 0 and 18% for PRP-D, PRP-T and HbOC, respectively. The difference in the occurrence of antigenuria resulting from each vaccine was statistically significant on Day 1 and for PRP-D compared with PRP-T or HbOC on Day 3. It is important for clinicians to be aware of the frequency with which antigenuria occurs after these vaccines so that appropriate therapeutic decisions can be made.

    Title Simultaneous Administration of Measles-mumps-rubella Vaccine with Booster Doses of Diphtheria-tetanus-pertussis and Poliovirus Vaccines.
    Date March 1988
    Journal Pediatrics
    Excerpt

    The safety and efficacy of simultaneous administration of measles-mumps-rubella (MMR), diphtheria-tetanus-pertussis (DTP), and trivalent oral poliovirus (OPV) vaccines in a test group of 405 children were compared with the safety and efficacy of sequential administration of the same vaccines in a control group of 410 children given MMR followed by booster doses of DTP and OPV 2 months later. The study was double blind and placebo controlled with respect to DTP and OPV. Seroconversion rates to measles, mumps, and rubella exceeded 96% in both groups. Geometric mean titers to measles (P = .05) and rubella (P = .004) were higher in the test group, and titers of antibodies to the other seven antigens were similar in both groups. Clinical reaction data were analyzed in 248 of 405 test children and 249 of 410 control children. The rates of serious vaccine-associated reactions were low and similar in the two groups. Some minor side effects were reported more frequently in the test group, but these differences were judged to be related to study design rather than to differences in the safety of the two vaccine schedules. The results indicate that the safety and serologic efficacy of administering MMR simultaneously with reinforcing doses of DTP and OPV in the second year of life is equivalent to the safety and efficacy observed after administering these antigens separately.

    Title Wanted: Chairpersons.
    Date January 1986
    Journal Journal of Medical Education
    Title Medicine in the Movies.
    Date July 1985
    Journal Postgraduate Medicine
    Title The Battered Parent Syndrome.
    Date September 1974
    Journal The Journal of Pediatrics
    Title A New Concept in Pediatric Practice: the University-affiliated Group Practice.
    Date March 1974
    Journal The Journal of Pediatrics
    Title Further Elucidation of Medical Jargon.
    Date March 1972
    Journal The New England Journal of Medicine

    Similar doctors nearby

    Dr. Malcolm Sitkoff

    Pediatrics
    Philadelphia, PA

    Dr. Zarrin Shouraie

    Pediatrics
    41 years experience
    Philadelphia, PA

    Dr. Thomas Coyte

    Pediatrics
    16 years experience
    Philadelphia, PA

    Dr. Barbara Gold

    Pediatrics
    32 years experience
    Philadelphia, PA

    Dr. Amy Bridgeman

    Pediatrics
    5 years experience
    Philadelphia, PA

    Dr. Alanna Kramer

    Pediatrics
    15 years experience
    Philadelphia, PA
    Search All Similar Doctors